Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Different Types of Fruits on Metabolic Function and Cognitive Performance (WBB2)

The Effect of Different Types of Fruits on Metabolic Function and Cognitive Performance

Primary objective is to assess the effect of the intake of different types of fruits on memory and attention.

Secondary objective is to assess effect of intake of different types of fruits on metabolic markers, including glucose, insulin, total cholesterol and triglyceride and the pharmacokinetic profile of the anthocyanins.

Panoramica dello studio

Stato

Completato

Condizioni

Descrizione dettagliata

The trial is designed as a randomized 2-arm, placebo-controlled, within-subjects crossover utilizing a multiple sampling, repeated measures paradigm to investigate the effects of consumption of different types of fruits on cognitive performance and metabolic responses. This trial will test 2 treatment conditions in forty men and women who will be enrolled into the study.

Each subject will be asked to come for one screening visit, a pre-study visit, and two dinner pick-ups the day before each of the two test visits and 2 test visits. Participation in this study will last approximately four weeks.

The initial screening visit will provide the subject with the informed consent document and determine eligibility through anthropometric measurements, vital signs, fasting blood glucose test , vein assessment, color test and completion of a survey relate to general eating, health, and exercise habits. In addition, subjects will take brief tests of attention and memory to ensure capability and willingness to perform tests during subsequent research visits. Eligible subjects will be trained and instructed to record all food and beverages consumed for a 3-day period (one weekend day and two weekdays) on food record diaries. At the pre-study visit, subjects will be instructed to follow a strictly limited polyphenolic diet for 7 days prior to the study and throughout their participation time, while maintaining their usual diet pattern and physical activity. A dinner meal will be provided the day before the study visit.

At each test visit, subjects will arrive at the clinic after fasting 8 to 12 hours and in a well-hydrated state. After confirming compliance with protocol, anthropometric measurements and vital signs will be taken along with a finger prick for fasting blood glucose and a catheter placement .

Fasting baseline blood sample from a catheter will be collected after which baseline cognitive performance measures will be assessed. After completing baseline measures, subjects will receive a standard breakfast meal along with a beverage containing different fruits according to the randomization sequence. Additional blood samples will be taken at 30, 60, 120, 180, 240, 300, 360, and 480 minutes after the start of the breakfast meal. Additional cognitive tests will be performed at the 120, 240, 360, and 480 minute time points. A standardized lunch will be provided between the 360 and 480 minute time points.

Subject will come to the clinic for 2 test day visits; all procedures will be the same except for the treatment (the test or control treatment).

Tipo di studio

Interventistico

Iscrizione (Effettivo)

40

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

    • Illinois
      • Chicago, Illinois, Stati Uniti, 60616
        • Clinical Nutrition Research Center

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 40 anni a 65 anni (Adulto, Adulto più anziano)

Accetta volontari sani

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • • Subject is male or female aged between 40 and 65 years of age

    • Subject has BMI between 18.5 and 34.9 kg/m2, (inclusive) at screening visit
    • Fasting blood sugar less than 126 mg/dL
    • Average Blood pressure less than 160/100 mmHg
    • Subject is willing to maintain a stable body weight and to follow his/her regular diet and physical activity patterns throughout the study period.
    • Subject is willing to refrain from vigorous physical activity and consumption of alcoholic and/or caffeinated beverages 24 h prior to each test day
    • Subject does not smoke or has abstained from smoking for at least 2 years
    • No clinical evidence of cardiovascular, metabolic, respiratory, renal, gastrointestinal or hepatic disease
    • Not taking any medications or dietary supplements that would interfere with outcomes of the study.

Exclusion Criteria:

  • • Subject currently smokes or has smoked within the past 2 years

    • Subject works overnight i.e. the night shift
    • Subjects who have a significant sleep disorder, a traumatic brain injury, have a learning disability or attention deficit disorder or any psychiatric or neurological disturbances
    • Subject is color blind, has impaired cognitive performance on the flanker test (score <60 at screening) or has a vein access score <7
    • Men and women with known or suspected food intolerance, allergies or hypersensitivity to the study materials or closely related compounds
    • Men and women known to have/diagnosed with diabetes mellitus
    • Men and women with a fasting blood glucose concentration ≥126 mg/dL
    • Average blood pressure > 160/100 mmHg during screening visit
    • Men and women with documented vascular disease, e.g., heart failure, myocardial infarction, stroke, angina, related surgeries
    • Men and women with cancer other than non-melanoma skin cancer in previous 2 years
    • Men and women who are taking medication or dietary supplements that may interfere with the study procedures or the endpoints of the study (e.g. antioxidants, anti-inflammatory medications, antidepressant medications, oral and injectable hypoglycemic medications, GI medications, antibiotics, diuretics, adrenergic blockers etc.) Subjects may choose to go off dietary supplements (requires 30 days washout)
    • Men and women taking antibiotics within 5 days of study start
    • Men and women who have donated blood/plasma within 3 months of the screening visit and blood donors/participants for whom participation in this study will result in having donated more than 1500 milliliters of blood in the previous 12 months
    • Substance (alcohol or drug) abuse within the last 2 years
    • Excessive coffee and tea consumption (> 4 cups/day)
    • Unstable body weight fluctuations of >4.5kg (9.9lbs) in the past 4 weeks
    • Women who are known to be pregnant or who are intending to become pregnant over the course of the study and women who are lactating.
    • Men and women whom investigator is uncertain about subject's capability or willingness to comply with protocol requirements
    • Women who are taking unstable dose and brand of hormonal contraceptives and/or stable dose and brand less than 6 months.
    • Men and women who do excessive exercise regularly or are athlete

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Scienza basilare
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione incrociata
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Treatment 1 Beverage
Treatment 1
Treatment 1 Beverage
Comparatore placebo: Treatment 2 Beverage
Treatment 2
Treatment 2 Beverage

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Changes in memory function using the Montreal Cognitive Assessment after intake of different types of fruits
Lasso di tempo: 8 hours Postprandial Study
Sum all sub-scores of the Montreal Cognitive Assessment
8 hours Postprandial Study

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Changes in plasma glucose concentrations after intake of different types of fruits
Lasso di tempo: 8 hours Postprandial Study
plasma glucose concentrations after intake of different types of fruits
8 hours Postprandial Study
Changes in plasma insulin concentrations after intake of different types of fruits
Lasso di tempo: 8 hours Postprandial Study
insulin concentrations after intake of different types of fruits
8 hours Postprandial Study
Changes in plasma Triglycerides Concentrations after intake of different types of fruits
Lasso di tempo: 8 hours Postprandial Study
Plasma Triglycerides Concentrations after intake of different types of fruits
8 hours Postprandial Study
Changes in plasma Total Cholesterol Concentrations after intake of different types of fruits
Lasso di tempo: 8 hours Postprandial Study
plasma Total Cholesterol Concentrations after intake of different types of fruits
8 hours Postprandial Study

Altre misure di risultato

Misura del risultato
Misura Descrizione
Lasso di tempo
Changes in polyphenol anthocyanin concentrations after intake of different types of fruits
Lasso di tempo: 8 hours Postprandial Study
polyphenol anthocyanin concentrations after intake of different types of fruits
8 hours Postprandial Study
Changes in LDL oxidation after intake of different types of fruits
Lasso di tempo: 8 hours Postprandial Study
OxLDL after intake of different types of fruits
8 hours Postprandial Study
Changes in IL-6 after intake of different types of fruits
Lasso di tempo: 8 hours Postprandial Study
IL-6 after intake of different types of fruits
8 hours Postprandial Study
Changes in IL-1beta after intake of different types of fruits
Lasso di tempo: 8 hours Postprandial Study
IL-1beta after intake of different types of fruits
8 hours Postprandial Study
Changes in IL-10 after intake of different types of fruits
Lasso di tempo: 8 hours Postprandial Study
IL-10 after intake of different types of fruits
8 hours Postprandial Study
Changes in MCP-1 after intake of different types of fruits
Lasso di tempo: 8 hours Postprandial Study
MCP-1 after intake of different types of fruits
8 hours Postprandial Study

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

2 marzo 2016

Completamento primario (Effettivo)

30 ottobre 2019

Completamento dello studio (Effettivo)

30 luglio 2020

Date di iscrizione allo studio

Primo inviato

31 marzo 2016

Primo inviato che soddisfa i criteri di controllo qualità

12 aprile 2016

Primo Inserito (Stima)

13 aprile 2016

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

27 luglio 2021

Ultimo aggiornamento inviato che soddisfa i criteri QC

26 luglio 2021

Ultimo verificato

1 luglio 2021

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • IRB2015-105

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Prove cliniche su Treatment 1

Sottoscrivi